Wendan Hou received a BS in bioengineering from China Pharmaceutical University and an MS in pharmacology from Lanzhou University. Wendan has five years of GLP experience in utilizing rodents, dogs, rabbits, and nonhuman primates in preclinical safety assessment programs. She is currently a research specialist in Professor Jeffrey Hubbell's laboratory.
Cellular and molecular biology and cancer immunotherapy.